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Abstract
The metabolism of radioiodinated apo B-100 in large VLDL
from normal and Watanabe heritable hyperlipidemic (WHHL)
rabbits, with diameters exceeding 450 A, was studied in corre-
sponding recipient rabbits. In both cases - 87% of the parti-
cles contained apolipoprotein (apo) E (B,E particles). In nor-
mal rabbits, apo B in these B,E particles was removed from
blood plasma much more rapidly than apo B in B,E particles in
smaller VLDL and few of the large B,E particles were con-
verted to lipoproteins of higher density. In WHHL rabbits,
- 60% of the apo B in B,E particles in large VLDL was re-
moved at a comparably rapid rate, but an appreciable fraction
of the remainder, which was removed slowly, was converted to
particles of higher density, as are the B,E particles in smaller
VLDL. From kinetic analysis of these and other data, an hy-
pothesis was formulated from which it is estimated that apo B
in large VLDL accounts for 18 and 41% of apo B transport in
normal and WHHL rabbits, respectively, despite the fact that
these lipoproteins contain < 5% of the apo B in total VLDL.
Failure to account for the contribution of large VLDL to
VLDL turnover may lead to serious underestimation of total
apo B transport in the blood.
Introduction
Recent research has suggested that the presence of apo E on
VLDL particles in rabbit blood plasma has a major influence
on their metabolism (1, 2). In normal New Zealand white
(NZW)' rabbits, most VLDL particles contain apo E as well as
apo B- 100 (B,E particles), but others lack apo E (B particles).
B,E particles in VLDL are removed from the blood much
more rapidly than B particles and a smaller fraction of B,E
particles is converted to particles of higher density, including
intermediate density lipoproteins (IDL) and LDL. We have
proposed that the presence of more than one molecule of apo
E on VLDL particles enhances their binding to LDL receptors
in the liver, promoting their removal from the blood and limit-
ing their conversion to IDL and LDL.
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1. Abbreviations used in this paper: NZW, New Zealand White (rab-
bits); WHHL, Watanabe heritable hyperlipidemic (rabbits).
In Watanabe heritable hyperlipidemic (WHHL) rabbits,
which are grossly deficient (but perhaps not totally lacking) in
functional LDL receptors, VLDL accumulate in the blood as a
result of impaired hepatic uptake and a larger fraction is con-
verted to IDL and LDL than in normal rabbits, consistent with
a key role for the LDL receptor in the direct removal of par-
tially metabolized VLDL (VLDL remnants) from the blood (2,
3). However, as in normal rabbits, B,E particles in VLDL of
WHHL rabbits are removed directly from the blood much
more efficiently than B particles (2). This observation led us to
propose that some VLDL particles (possibly those that contain
several molecules of apo E) are removed from the blood of
WHHL rabbits by interaction with a lipoprotein receptor, ei-
ther the chylomicron remnant receptor or the structurally ab-
normal LDL receptor that is known to be synthesized in
WHHL rabbits (2, 4). Although the mutant receptor in
WHHL rabbits is poorly glycosylated, a fraction may be trans-
ported to the plasma membrane of cells. In humans, large
VLDL particles are removed from the blood much more rap-
idly than smaller ones and few large VLDL are converted to
lipoproteins of higher density (5, 6). In the current research, we
have therefore tested the hypothesis that large VLDL make a
substantial contribution to the transport of particles contain-
ing apo B into the blood of both normal and receptor-deficient
rabbits. Our results provide support for this hypothesis, despite
the fact that large VLDL account for only a small fraction of
the VLDL present in blood plasma.
Methods
Animals. Male NZW rabbits weighing 2.2-2.8 kg and WHHL rabbits
weighing 2.1-2.7 kg were fed Purina Lab Rabbit chow (Ralston Purina
Co., St. Louis, MO). Before and during in vivo experiments, the ani-
mals were kept in individual cages (1). The mean plasma total choles-
terol and triglyceride concentrations were 33 and 81 mg/dl in NZW
rabbits; corresponding values in WHHL rabbits were 496 and 373
mg/dl.
Preparation of lipoproteins. Blood was withdrawn from a femoral
vein of tranquilized donor rabbits (1) and mixed with disodium EDTA
(1 mg/ml), sodium azide (0.2 mg/ml), and gentamycin (10 gg/ml), pH
7.4 (buffer A). Fresh plasma, obtained at 40C, was centrifuged in a
Beckman SW 41 rotor (Beckman Instruments, Inc., Fullerton, CA) at
10,000 rpm for 30 min at 12'C to minimize contamination ofVLDL
with particles containing apo B-48; the top 1 ml of the tube contents
was removed by tube slicing. "Large" VLDL were then isolated from
the remaining plasma in an SW 41 rotor at 39,000 rpm for 1 h at 12'C;
the top 1 ml was obtained by tube slicing. This lipoprotein fraction was
layered beneath 1.5 ml 0.075 M NaCl and centrifuged twice under the
same conditions, dialyzed against 0.15 M NaCl containing 0.01% di-
sodium EDTA, 0.02% sodium azide, pH 7.4, and iodinated with 125I
(Amersham Corp., Arlington Heights, IL) by a modification of the
method of McFarlane (7) to a specific activity of 50-250 dpm/ng
protein. Free iodine was removed on a column (I X 10 cm) of Sepha-
dex G-50 (Pharmacia Fine Chemicals, Piscataway, NJ). As determined
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by assay of components separated by SDS gel electrophoresis (5) from
two preparations from NZW rabbits and one preparation from WHHL
rabbits, 90-92% of the '25I-apo B in large VLDL from both NZW and
WHHL rabbits was in apo B- 100 and 8-10% in apo B-48. The percent-
age of total radioiodine in apo B, measured as 25I insoluble in 50%
isopropanol, was - 29 in large VLDL from NZW rabbits and 15 in
that from WHHL rabbits. The labeled lipoproteins (0.5-1.0 mg pro-
tein) were mixed with 1 ml ofdonor plasma and dialyzed twice against
4 liters of buffer A at 4VC. Before injection into animals, the iodinated
lipoproteins were dialyzed against 0. 15 M NaCI for 1-2 h and passed
through a 0.22-,um filter (Gelman Sciences, Inc., Ann Arbor, MI). In
some experiments, VLDL were separated from fresh plasma on a 2
X 90-cm column of4% agarose gel (Bio-Gel A- 15 M; Bio-Rad Labora-
tories, Richmond, CA) (8).
Lipoprotein kinetics in vivo. Large VLDL (30-60 ,Ci) were injected
into an ear vein of unanesthetized animals at - 9 a.m. Blood samples
of 2 ml were taken from an opposite ear vein into tubes containing 2
mg disodium EDTA and 0.4 mg sodium azide 3, 30, 90, 180, 360, 720,
and 1,440 min after injection and placed on ice. Plasma was separated
by centrifugation at 40C.
Immunoaffinity chromatography and density gradient ultracentrif-
ugation. B and B,E particles were separated from 0.02 to 0.10 ml whole
rabbit plasma on columns of affinity-purified sheep antirabbit apo E
coupled to Sepharose 4B (2). The unbound fraction of plasma applied
to the column contained no detectable apo E by RIA (9). Samples of
plasma were also subjected to density gradient ultracentrifugation and
12 fractions with densities ranging from 1.005 to 1.050 g/ml were
obtained as described (2).
Measurement of radioiodine in apo B. Radioiodine in apo B of
whole plasma and in the fraction that did not bind to the immunoaf-
finity column (B particles) was assayed as described (10). Radioiodine
in apo B of lipoproteins bound to the column (B,E particles) was
determined by subtracting radioactivity in apo B of the unbound frac-
tion from that of apo B in whole plasma.
To determine the fraction of labeled apo B in total VLDL that is
accounted for by large VLDL, total VLDL from each of five NZW
rabbits were radioiodinated. The labeled VLDL were centrifuged as
described above for separation of large VLDL, and portions of the
supernatant (which contained large VLDL together with some con-
taminating smaller VLDL particles) and the infranatant were taken for
assay of '25I-apo B. The remainder of the supernatant was recentri-
fuged under the same conditions and the infranatant was taken for
assay of '25I-apo B. Apo B radioactivity in large VLDL was calculated
from the difference between that in the supernatant from the first
centrifugation and the infranatant from the second centrifugation.
Apo B radioactivity in the remainder of the VLDL particles was cal-
culated as the sum of that in the infranatants from the two centrifuga-
tions.
Lipoprotein analysis. Total cholesterol and triglycerides were mea-
sured in plasma by an automated chemical method (1 1). Total choles-
terol, free cholesterol, and triglycerides in lipoprotein fractions were
measured by enzymatic methods (12, 13). Phospholipids were esti-
mated from content of lipid phosphorus (14), and protein was mea-
sured by a modified Lowry procedure (15). Apo B was estimated as
isopropanol-insoluble protein (1). Electron microscopy of lipoproteins
was performed on samples negatively stained with potassium phos-
photungstate ( 16). Particle diameters were measured on the photogra-
phic prints at a magnification of 180,000 (9).
Kinetic analysis. The concentration of '25I-apo B in B,E and B
particles in whole plasma was measured in six NZW rabbits and four
WHHL rabbits after injection of large VLDL. Inspection of the data
revealed that a significant portion ofB,E and B particles in large VLDL
ofNZW rabbits and of B,E particles in large VLDL ofWHHL rabbits
have residence times considerably shorter than those seen when total
VLDL are injected (2). These new data, averaged for NZW and
WHHL rabbits, together with previously published data on B,E and B
particle kinetics after injection of total VLDL (2), were used to con-
struct a mechanistic hypothesis describing the kinetics of large, rapidly
turning-over VLDL particles in NZW and WHHL rabbits. Our analy-
sis indicated that in NZW rabbits, most but not all of the B,E and B
particles in large VLDL turn over rapidly. In the following, we will
refer to these rapidly turning-over over particles as "fast B,E" and "fast
B" particles. The remaining particles in large VLDL, like the great
majority of those in total VLDL, will be referred to as "slow B,E" and
"slow B" particles. The fast B,E and B particles are not clearly evident
upon inspection of the disappearance data in whole plasma when total
VLDL are injected because they constitute only a small fraction of
total VLDL particle number (see below). A similar situation was found
to exist in WHHL rabbits.
The modeling process was performed with the SAAM 27 computer
program (17, 18). The following hypotheses were tested. (a) Fast B,E
and B particles in both NZW and WHHL rabbits are delivered to the
plasma and exit the plasma without conversion to slow VLDL parti-
cles, IDL, or LDL. (b) The residence times of fast B,E particles in NZW
and WHHL rabbits are equal and very short as compared with those of
slow B,E particles. (c) The fractional rates ofirreversible loss of fast and
slow B particles from the plasma ofNZW andWHHL rabbits are equal
to the corresponding fractional rates of irreversible loss of LDL parti-
cles from plasma. (d) Fast B particles in NZW and WHHL rabbits are
partially converted to fast B,E particles. (e) The fractional conversion
of slow B,E and B particles in VLDL to B,E and B particles in IDL is
equal but different in NZW and WHHL rabbits. (f) All apo B enters
the plasma as VLDL (19).
The percentage of whole VLDL in NZW rabbits represented by
large particles was determined experimentally and contains a high
proportion of fast B,E and B particles, together with some slow B,E and
B particles (see Results). This differs from total VLDL, in which nearly
all the B,E and B particles are slow. Therefore, although both sets of
tracer data (after injection of large and total VLDL) in NZW and
WHHL rabbits contain both fast and slow B,E and B particles, the
presence of the fast particles is much more obvious after injection of
large VLDL. IDL and LDL subsystem kinetics in NZW and WHHL
rabbits are assumed known from our previous data and analysis (1, 2).
As in our previous work (1, 2), the whole plasma tracer data for NZW
and WHHL rabbits are analyzed as combinations of radiolabeled apo
B in fast VLDL, slow VLDL, IDL, and LDL in either B,E or B parti-
cles.
Given our new data on large VLDL together with our previous
analyses for total VLDL, IDL, and LDL and applying the hypotheses
stated above, the rate constants for only four pathways are adjustable
in the model solution for NZW rabbits and for three pathways in the
model solution for WHHL rabbits. In Fig. 4 and 5, these pathways are
indicated by heavy arrows. In NZW rabbits, the four rate constants
include (a) the fractional rate of irreversible loss of fast VLDL B,E
particles from plasma; (b) the fractional rate of irreversible loss ofslow
VLDL B,E particles from plasma; (c) the fractional rate of conversion
of fast B particles to fast B,E particles in VLDL; (d) the fractional rate
of conversion of slow VLDL B,E particles to IDL B,E particles. The
three adjustable rate constants for WHHL rabbits include all but the
first of these.
The model requires 16 initial conditions (four for each injection of
large and total VLDL in NZW and WHHL rabbits) to be established
from eight sets of tracer data (plasma '251I-apo B in B,E and B particles
after large and total VLDL injections in NZW and WHHL rabbits).
This was accomplished with the adjustable initial condition feature of
the SAAM 27 program after various constraints were applied to pro-
vide uniqueness (see Appendix). The concentrations of apo B in fast
and slow B,E and B particles in total VLDL of NZW and WHHL
rabbits were calculated from the measured B,E and B particle concen-
trations of apo B in total VLDL (2) and from the relative concentra-
tions of '251I-apo B in fast and slow B,E and B particles in total VLDL.
The latter were determined from the estimated initial conditions of fast
and slow B,E and B particles in radiolabeled total VLDL ofNZW and
WHHL rabbits. The details ofthese calculations, which are based upon
the tracer data and measurement of the fraction of apo B in total
VLDL that is large, are given in the Appendix. Using these calculated
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values for the concentrations of fast and slow B,E and B particles in
VLDL, a steady state solution was obtained for both NZW and WHHL
rabbits, yielding the transport rates ofapo B in VLDL, as well as in IDL
and LDL. The measured steady state concentrations of apo B in B,E
and B particles in IDL and LDL in NZW and WHHL rabbits (2) were
weighted in the data set and served to constrain the model fits to the
tracer data. All adjustable parameters and initial conditions were fitted
to the eight sets of tracer data for apo B in whole plasma at the same
time using the multiple study capability of the SAAM 27 program.
The uncertainties of the adjustable model parameters and the ad-
justable initial conditions were estimated from the variance-covariance
matrix in the neighborhood of the least-squares fit. The details of the
fitting procedure have been presented elsewhere (1, 2).
Results
Large VLDL from NZW and WHHL rabbits were of similar
size, with mean diameters, estimated from their composition
(20), of 641 and 702 A, respectively. As with total VLDL, large
VLDL from WHHL rabbits contained more cholesteryl esters
and less triglycerides than those from NZW rabbits (Table I).
The distributions of particle size in electron micrographs of
negatively stained preparations of large VLDL from NZW and
WHHL rabbits were similar (Fig. 1). More than 80% ofparticle
diameters were between 500 and 900 A, whereas particle diam-
eters of > 90% of total VLDL were below 500 A. By direct
measurement, apo B in large VLDL of NZW rabbits com-
prised 5.26% (n = 5, SEM = 0.90) of that in total VLDL. The
number of apo E molecules per particle of large VLDL (which
had been subjected to ultracentrifugation three times) was less
than two, as estimated from the molar ratio ofapo E to apo B.
In VLDL fractions ofwhole plasma eluted from 4% agarose gel
columns, the E:B ratio increased progressively with particle
size, from 1.30 to 2.63 in NZW rabbits and from 1.18 to 2.52
in WHHL rabbits. However, the concentration ofapo E in the
largest particles, which represented 12 and 6% of the mass of
apo B in VLDL from NZW and WHHL rabbits, respectively,
was below the limit of sensitivity ofthe apo E RIA. About 87%
of '251-apo B in large VLDL from both NZW and WHHL
rabbits was in BE particles (Table II). Similar values were
obtained for total VLDL from WHHL rabbits, whereas a
lower value (75%) was found for total VLDL from NZW rab-
bits.
Table I. Composition ofPlasma VLDL
NZW WHHL
Total Large Total Large
(n = 6) (n = 7) (n = 6) (n = 3)
% mass
Cholesteryl ester 5.7±1.3 3.4±1.2 26.5±5.8 14.7±13.0
Triglyceride 58.7±4.2 74.6±4.4 39.4±0.8 65.6±16.9
Cholesterol 5.7±1.0 3.3±0.7 5.8±0.6 3.9±2.2
Phospholipid 18.9±2.1 12.9±1.5 17.4±5.4 12.0±2.0
Protein 11.2±1.6 5.7±1.9 10.1±1.5 3.9±0.7
Diameter (A)* 367 641 390 702
Molar ratio:
E/B1 2.09 1.65 2.40 1.86
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Figure 1. Distribution
of particle diameters
measured on photogra-
phic prints of negatively
stained rabbit VLDL.
(Closed columns) Total
VLDL, mean values for
four samples from
NZW rabbits and two
samples from WHHL
rabbits. (Open columns)
Large VLDL, mean
values for two samples
each from NZW and
WHHL rabbits.
The kinetics of removal of radioiodine in total apo B from
blood plasma after injection of labeled large VLDL into NZW
and WHHL rabbits are shown in Fig. 2 and compared with
those observed after injection of total VLDL. In both groups of
rabbits, 125i in apo B of large VLDL was removed from plasma
much more rapidly than that of total VLDL. In NZW rabbits,
75% was removed during the first 30 min and < 1% remained
after 12 h. In WHHL rabbits, almost 50% was removed during
the first 30 min, but thereafter the rate of removal slowed
markedly and resembled that of apo B in total VLDL. In all
cases, 125I-apo B in B,E particles was removed more rapidly
than that in B particles (Fig. 3). In NZW rabbits, both B,E and
B particles in large VLDL were removed more rapidly than
their counterparts in total VLDL. In WHHL rabbits, B,E par-
ticles in large VLDL were initially removed more rapidly than
those in total VLDL. As these figures demonstrate, the model
solutions fit the tracer data well.
The fractional turnover rates (h-'), transport rates
(mg. dl-' * h-') and calculated concentration (mg. dl-'), based
on both sets of injections into NZW rabbits, are shown with
the model in Fig. 4 and those for WHHL rabbits are shown in
Fig. 5. All adjustable parameters and initial conditions were
well determined with maximum fractional standard deviation
(FSD) of 0.19 and average FSD of 0.06. The calculated initial
distributions of '25I-apo B for total VLDL and large VLDL
injections into NZW and WHHL rabbits, expressed as percent
Table II. Distribution of')2I-apo B between B and B,E
Particles in Plasma VLDL
Total VLDL Large VLDL
NZW WHHL NZW WHHL
B,E particles 75.2±4.4 87.7±3.9 87.7±2.7 85.6±4.1
B particles 24.8±4.3 12.3±3.8 12.3±2.3 14.4±3.5
Values are mean percentages±SD for four to six samples.
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* Calculated from composition (20).
* Based on M, for apo B of 512,000 and for apo E of 34,000.
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Figure 2. Removal of
'25I-apo B from whole
blood plasma after in-
jection of homologous
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WHHL rabbits. Mean
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of total radioactivity in VLDL apo B, are shown in Table III.
The percent of radiolabeled apo B in fast B,E and B particles in
total VLDL can be calculated to be 5.0 and 3.3% in NZW and
WHHL rabbits, respectively. Assuming that apo B labeling is
proportional to apo B mass (2), these percentages also reflect
the relative concentrations of apo B in fast B,E and B particles
in these rabbits, as shown in Figs. 4 and 5.
The total apo B production rates in NZW and WHHL
rabbits are calculated to be 9.53 and 8.23 mg dl- .h-, re-
spectively. The fractions of the apo B production rates repre-
sented by fast particles are 18 and 41% in NZW and WHHL
rabbits, respectively. The fractions represented by B,E particles
(fast and slow) are 92 and 95%, respectively. The discrepancy
between production rate and mass is particularly large for fast
B,E particles in WHHL rabbits for which the fractional irre-
versible disposal rate exceeds that of slow B,E particles by
B,E
Fast Slow
1.69 7.03
VLDL
IDL
LDL
B
Slow Fast
1 .74
.175
Figure 4. Multicompartmental model of the metabolism of apo
B- 100 in NZW rabbits. Solution from analysis of data on B,E and B
particles in whole plasma after injection of large VLDL, total VLDL,
IDL, and LDL. The concentrations (mg/dl) of B,E and B particles of
lipoprotein classes in the intravascular compartment are shown
within the circles. Empty circles represent extravascular compart-
ments for IDL and LDL. Transport rates (mg. dl-' h-') are under-
lined. Small, italicized numbers are rate constants (h-'). Adjustable
rate constants are shown with heavy arrows. VLDL include fast and
slow components for both B,E and B particles; the fast components,
which represent - 95% of large VLDL injected in the current study,
represent only - 5% ofVLDL apo B mass (see Table III).
- 50-fold. These fast B,E particles account for 41% of total
apo B transport, but only 2.8% ofapo B mass (Fig. 5 and Table
III, respectively).
B,E
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B
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Figure 3. Removal from whole blood plasma of '25I-apo B in B,E
and B particles after injection of homologous radioiodinated lipopro-
teins into rabbits. Data are from the same experiments shown in Fig.
2. Bars represent SE (where not shown, SE values fall within data
points). The curves were derived from kinetic analysis of the data
using the model shown in Figs. 4 and 5.
LDL
Figure 5. Multicompartmental model of the metabolism of apo
B- 100 in WHHL rabbits: solution from analysis of the data on B,E
and B particles in whole plasma after injection of large VLDL, total
VLDL, IDL, and LDL. Circles, arrows, and numbers are represented
as in Fig. 4. VLDL include fast and slow components for both B,E
and B particles; the fast components, which represent - 62% of large
VLDL injected in the current study, represent only - 3% of VLDL
apo B mass (see Table III).
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Table III. Calculated Initial Distributions of
'25I-Apo B in Kinetically Fast and Slow BE and B Particles
after Injection of Total and Large VLDL
Percent '251-apo B
Total VLDL Large VLDL
NZW WHHL NZW WHHL
B,E particles
Fast 4.4 2.8 83.8 52.9
Slow 72.8 84.9 3.9 32.7
B particles
Fast 0.6 0.5 11.1 8.9
Slow 22.2 11.8 1.2 5.5
The model assumption that fast VLDL particles are not
converted to IDL and LDL is supported by analyses of the
distribution of '25I-apo B in lipoprotein fractions obtained
after density gradient ultracentrifugation of the samples taken
up to 24 h after injection of large VLDL. In NZW rabbits, 125I
rose to - 8% of injected '251-apo B in lipoproteins with densi-
ties > 1.006 g/ml 30 min after injection, but quickly fell to
undetectable levels (< 0.5%). These small amounts of '25I-apo
B in IDL + LDL probably reflect incomplete flotation of
VLDL. In WHHL rabbits, very little '25I-apo B appeared in
lipoproteins denser than 1.006 g/ml during the rapid phase of
removal (up to 30 min after injection). Thereafter, '251I-apo B
appeared gradually in lipoproteins of progressively increasing
density up to 1.04 g/ml, accounting for 8% of injected '25I-apo
B 6 h after injection (data not shown). This indicates that some
of the apo B in the injected large VLDL of WHHL rabbits,
with kinetic behavior similar to that of the majority ofVLDL
particles, was converted to IDL and LDL.
Discussion
In our earlier studies of the metabolism of apo B-100 in
WHHL rabbits (2), we observed that the fractional rate of
irreversible loss of VLDL B,E particles from plasma consider-
ably exceeded that of B,E particles in IDL or LDL, as well as
those of B particles in all density classes of lipoproteins con-
taining this apoprotein. A plausible explanation of this obser-
vation is that some VLDL B,E particles are recognized by a
lipoprotein receptor in these LDL receptor-deficient animals.
Since we had observed that large VLDL (with diameters ex-
ceeding 470 A) are removed from the blood of humans much
more rapidly than the majority ofVLDL particles and at rates
approaching those expected for chylomicrons (5), we have
evaluated the metabolism of similarly large VLDL in blood
plasma of NZW as well as WHHL rabbits. In both groups of
rabbits, only a small fraction of VLDL particles has diameters
> 500 A. Hence, to prepare VLDL of this size it was necessary
to subject them to repeated flotation to reduce to low levels
particles < 500 A. Most of the large VLDL obtained from both
groups of rabbits were > 90% of total VLDL and most ofthem
contained apo E. However, the number of apo E molecules
found per particle was less than that expected from previous
observations of human VLDL (21). Since the lipoproteins had
been ultracentrifuged three times, an appreciable fraction of
the apo E may have been dissociated. This possibility is con-
sistent with the ratios found in subfractions of VLDL sepa-
rated from whole plasma by gel chromatography. For this rea-
son, in the current experiments, as in those reported pre-
viously, we reincubated the radiolabeled lipoproteins with
plasma of the recipient animals before injection to permit
them to regain apo E.
The large VLDL we isolated account for only a small frac-
tion ofVLDL particles. Their fractional rate of irreversible loss
from plasma would therefore have to exceed that of the re-
mainder ofVLDL by severalfold for them to have an appreci-
able influence on the metabolism of total VLDL. Based on the
kinetic hypothesis presented here, we found this to be the case
in NZW rabbits, as in humans (5). The estimated fractional
rate of irreversible loss offast B,E particles in large VLDL from
plasma was fivefold greater than that of slow B,E particles. In
addition, consistent with previous observations ofthe behavior
of large human VLDL (5, 6), few of the large VLDL particles
were converted to particles more dense than 1.006 g/ml.
In WHHL rabbits, the fractional rate of irreversible loss of
60% of the B,E particles in large VLDL from plasma ex-
ceeded that ofB,E particles in smaller VLDL by a factor of 50.
Indeed, it was possible to constrain this fractional rate to be the
same as that observed for NZW rabbits, consistent with the
hypothesis that some VLDL B,E particles in WHHL rabbits
are metabolized normally. In this connection, three points
warrant emphasis. First, only - 9% of the labeled apo B of
large VLDL in WHHL rabbits was in apo B-48, but more than
one-half of the apo B in large VLDL was metabolized rapidly.
It follows that at least 80% of the apo B in rapidly metabolized
large VLDL was in apo B-100. Second, 40% of the apo B in
B,E particles of large VLDL (slow B,E particles) seems to be
removed from the blood with kinetics similar to those seen
when total VLDL are injected (i.e., 50-fold more slowly).
Third, the average fractional rate of irreversible loss from
plasma of slow B,E particles in VLDL was calculated to be
0.071 h-' (Fig. 5), a value about fivefold greater than that of
apo B in all other lipoprotein fractions. Such kinetic heteroge-
neity of VLDL in these receptor-deficient animals could be
related to variable content of apo E molecules or to variability
in the conformation of the receptor-binding domain of apo E.
Based upon the model presented above, the total apo B
production rate in WHHL rabbits is - 86% of that calculated
for NZW rabbits. This value compares favorably with the rela-
tive rates of accumulation of apo B in perfusates of isolated
livers from NZW and WHHL rabbits. The production rate of
apo B in WHHL rabbits was - 80% of that found in NZW
rabbits ( 19).
The disappearance of "25I in B particles from plasma after
injection of large VLDL into NZW and WHHL rabbits clearly
reveals a component that turns over more rapidly than that of
B particles after injection of total VLDL (Fig. 3). To explain
this phenomenon we have postulated that some fast B particles
are converted to fast B,E particles. The fractional rate of irre-
versible loss of B particles from plasma was assumed to be
equal to that of LDL B particles. Two other hypotheses,
equally consistent with the tracer data, are those of complete
rather than partial conversion of fast B particles to fast B,E
particles and of a fractional irreversible rate of loss of fast B
particles from plasma greater than that of LDL B particles. In
both of these cases, the main conclusions drawn from our
analysis would not be materially affected because less than 1%
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of the total apo B transport occurs through this fast B particle
pathway (Figs. 4 and 5).
The model solutions shown in Figs. 4 and 5 explain the
early rapid disappearance of B,E particles in large VLDL by
irreversible removal from plasma. We have evaluated several
other hypotheses that might explain this phenomenon. The
first is based upon the fact that triglyceride-rich lipoproteins
initially bind to lipoprotein lipase at the surface of capillary
endothelia. Particles that have a high affinity for the enzyme
might thereby leave the plasma rapidly, but transiently (22).
To test this hypothesis, we included in the model shown in
Figs. 4 and 5 an extravascular compartment that equilibrates
with the pool of fast B,E particles in plasma, and assumed that
there are no slow B,E particles in large VLDL. For NZW
rabbits, results consistent with the tracer data were obtained,
but only with a mass of apo B in the extravascular compart-
ment that exceeded that in plasma by a factor of 300. Since
such a massive compartment seems very unlikely, we have
rejected this hypothesis for NZW rabbits. For WHHL rabbits,
in which a substantial fraction of apo B in large VLDL re-
mained in plasma for a prolonged period of time, results con-
sistent with the tracer data were also obtained. In this case, the
mass ofapo B in the extravascular compartment exceeded that
in fast B,E particles in plasma by a factor ofabout three. Under
these conditions, the production rate of fast B,E particles is
only 0.20 mg * dl-' * h-', as compared with the value of 3.39
mg. dl-' * h-' shown in Fig. 5. The fractional rate of move-
ment of fast B,E particles into the extravascular pool is about
2.2 - h-', and the fractional rate of irreversible loss of fast B,E
particles from plasma is 0.14. h-', about double that for slow
B,E particles in VLDL. This hypothesis fails to explain the
observation that B,E particles in large VLDL that persisted in
the plasma of WHHL rabbits were converted appreciably to
IDL and LDL. Furthermore, this hypothesis is not consistent
with the relatively large size of the VLDL particles in isolated
liver perfusates from WHHL rabbits (19). Therefore, a second
alternative hypothesis was tested for WHHL rabbits, namely
that fast B,E particles in large VLDL rapidly bind to lipopro-
tein lipase sites on capillary endothelia and then return quanti-
tatively to the plasma as VLDL remnants (contained within
slow B,E particles), which are removed only slowly from
plasma, with gradual conversion to IDL and LDL. It was not
possible to fit this model to the tracer data, since the return of
remnant particles to the plasma yielded a substantial increase
in tracer shortly after its initial removal.
A third alternative hypothesis, which combines an extra-
vascular compartment equilibrating with fast B,E particles in
plasma with some conversion of extravascular B,E particles to
slow B,E particles in plasma was consistent with the data of
Fig. 3. However, like the first alternative hypothesis discussed
above, this one is not consistent with the rate of appearance of
apo B in IDL and LDL in WHHL rabbits during the first 6 h
after injection of large VLDL.
Finally, a fourth alternative hypothesis was tested that ex-
plains the kinetics of the disappearance of B,E and B particles
from plasma after injection of large VLDL by partial conver-
sion of fast B,E and B particles to slow B,E and B particles,
respectively. This hypothesis is overtly consistent with the
concept of a delipidation cascade in VLDL which is included
within the VLDL compartments of Figs. 4 and 5. It assumes
that all ofthe apo B in large VLDL is contained in fast B,E and
B particles. This model is consistent with all ofthe data shown
in Fig. 3 as well as the data from density gradient ultracentrifu-
gation. The transport rates for NZW and WHHL rabbits cal-
culated in the steady state solution of this model are generally
similar to those shown in Figs. 4 and 5, with the exception of
the production rate of fast B,E particles in WHHL rabbits.
This rate, 5.33 mg * dl-' * h-', is 65% of the total apo B produc-
tion rate in these animals and would require a very large aver-
age size of nascent lipoprotein particles. Given the data cur-
rently available, we cannot favor our initial hypothesis over
this alternative. Nevertheless, no major differences other than
the above exist between these two hypotheses.
The implications of our kinetic analysis are consistent with
our earlier suggestion that some particles containing apo B- 100
are removed from the blood by WHHL rabbits via interaction
with a lipoprotein receptor. Whether fast B,E particles are re-
moved by chylomicron remnant receptors or by structurally
abnormal LDL receptors that reach the surface of hepatocytes
remains uncertain. The fact that the fractional irreversible dis-
posal rates for fast B,E particles could be constrained to be
equal in NZW and WHHL rabbits is, however, consistent with
removal via a chylomicron remnant receptor.
The observations and analysis reported here are critical to
an understanding of the metabolism of particles containing
apo B- 100 in WHHL rabbits. They suggest that - 40% of the
secreted lipoprotein particles containing this protein are me-
tabolized rapidly and at an apparently normal rate in these
receptor-deficient animals. They lead to the prediction that the
secreted VLDL are considerably larger than those isolated
from plasma. The diameter of - 40% of secreted VLDL
should exceed 500 A, whereas only 3% of particles in plasma
VLDL are this large. Similar predictions apply to VLDL in
NZW rabbits. About 18% of secreted VLDL particles should
be larger than 500 A in diameter, compared with only about
5% ofthose in blood plasma. These implications ofour model,
that the size of secreted particles containing apo B is consider-
ably larger than that found in plasma and that this size is
greater in WHHL rabbits than in NZW rabbits, are consistent
with the observations of Hornick and associates on the size of
VLDL that accumulate in perfusates of isolated rabbit livers
(19). From their data on the composition of these VLDL, the
mean diameters of particles from liver perfusates from NZW
and WHHL rabbits weighing - 1.5 kg can be estimated to be
580 and 730 A, respectively. In addition, we have obtained
preliminary data which show that VLDL isolated from Golgi
apparatus-rich fractions of livers from NZW rabbits contain a
substantial fraction of particles with diameters exceeding 500
A (unpublished observations).
Our results indicate that experiments with total radioio-
dinated VLDL provide an incomplete picture of the metabo-
lism ofVLDL in NZW or WHHL rabbits. In both normal and
receptor-deficient animals, an appreciable fraction of secreted
VLDL is metabolized so rapidly that it contributes little to the
mass of plasma VLDL. The contribution of these particles to
the transport ofVLDL cannot be appreciated from the kinetics
of apo B in total plasma VLDL, given the sampling frequen-
cies we used and the level of analytical precision that we ob-
tained. In fact, the total apo B production rates in NZW and
WHHL rabbits, based on injection of labeled total VLDL pre-
viously reported by us, are 16 and 41% lower, respectively,
than those reported here. This underestimation is almost com-
pletely accounted for by failure to include transport through
the fast B,E pathway in VLDL.
Apolipoprotein B Kinetics in Normal and Watanabe Hyperlipidemic Rabbits 2111
These observations may have important implications for
the interpretation of the kinetics of plasma VLDL in other
species, including humans. Previous analyses of kinetic data
may underestimate the rate of entry of apo B- 100 into plasma
VLDL and overestimate the fraction of secreted VLDL parti-
cles that is converted to IDL and eventually to LDL. As indi-
cated from the current studies, the magnitude of such errors
may not be the same in different situations. Clearly, methods
such as those described here or other approaches are needed to
understand the influence of physiological and pathological
conditions on the rate of secretion of apo B- 100 from the liver
and the fate of particles containing this important protein.
Appendix
The modeling process we have performed is based on the presence of
both fast and slow B,E and B particles in large and total VLDL ofNZW
and WHHL rabbits. The presence of the fast B,E and B particles in
plasma after total VLDL injection is poorly reflected in the kinetics of
these particles due to their low concentration and the sampling fre-
quency employed. However, the kinetic behavior ofthese fast particles
is much better seen when their relative concentration is greatly in-
creased by ultracentrifugal isolation of large VLDL. Analysis of the
kinetics ofB,E and B particles after injection oflarge VLDL, combined
with a concurrent analysis of our data obtained after injection of total
VLDL, allows estimation of the initial conditions and relative concen-
trations of both fast and slow B,E and B particles in total VLDL.
A set of equations describing the initial conditions for the model
shown in Figs. 4 and 5, as fitted to the data of Fig. 3, can be elaborated
using adjustable parameters P(I) in the SAAM 27 computer program.
Let IC(I * J * K) be the initial condition where I is either a fast (f) or slow
(s) particle, J is either a B,E or B particle, and K is either an NZW (N)
or WHHL (W) rabbit. The IC(I . J * K) are expressed as percent of
injected dose; the plasma concentrations at time zero are assumed to
be 100%.
Total VLDL Large VLDL
IC(f- B,E * N) = P(l) IC(f B,E * N) = P(5)
NZW IC(s B,E * N) = P(2) IC(s B,E * N) = P(6)IC(f. B - N) = P(3) IC(f. B * N) = P(7)
IC(s B - N) = P(4) IC(s- B * N) = P(8)
IC(f. B,E * W) = P(9) IC(f- B,E * W) = P( 13)
WHHL IC(s * B,E * W) = P(l 0) IC(s * B,E * W) = P(14)
IC(f * B * W) = P( 1l) IC(f * B * W) = P(15)
IC(s * B * W) = P(12) IC(s* B * W) = P(16)
The following assumptions are applied to this set of equations
allowing a unique solution subject to the requirement of fitting the
tracer data shown in Fig. 3.
(1) Conservation of mass relations
4 8 12 16
2: P(I)= 2 P(I)= 2 P(I) = P(I) = 100,
1-1 1-5 1=9 1-13
allows P(4), P(8), P(12), and P(16) to become dependent.
(2) The percentage of total and large VLDL radioactivity consti-
tuted by B,E particles as shown in Table 2 is used to make P(2), P(6),
P(10), and P(14) dependent according to the equations below.
P(2) + P(l) = 75.2±4.4
P(6) + P(5) = 87.7±2.7
P(R0) + P(9) = 87.7+3.9
P(14) + P(13) = 85.6±4.1
The SAAM program allows dependence relations to be entered subject
to certain statistical constraints, as opposed to the more commonly
used absolute constraints. The calculated values for the P( 1) shown in
Table III do not satisfy the above four equations exactly, but are con-
sistent with these equations within the statistical ranges allowed. The
slight differences are the result of the requirement to produce the best
fit of the tracer data in Fig. 3 yet remain consistent with these depen-
dence relations.
(3) Knowledge of the percent of total VLDL apo B in the NZW
rabbit constituted by large VLDL apo B allows P( 1) to be dependent
according to the relation
P(l) = 5.26 X P(5)/100.
As shown in Table III, P(5) is calculated to be 83.8% of the apo B in
large VLDL in the NZW rabbits.
(4) The ratios of fast B,E particles to fast B particles in total VLDL
in NZW and WHHL rabbits are equal to those same ratios seen in large
VLDL where these ratios are easily resolvable from the tracer data.
These ratios allow P(3) and P( 11) to be made dependent according to
the relations
P(3)/P(l) = P(7)/P(5)
P(l 1)/P(9) = P(15)/P(13).
These relations assume that either all or a representative fraction offast
B,E and B particles in total VLDL are found in large VLDL in both
NZW and WHHL rabbits.
(5) The ratio of fast B,E particles in total VLDL in NZW rabbits to
fast B,E particles in total VLDL in WHHL rabbits is given by the same
ratio in large VLDL. This assumption allows P(9) to be made depen-
dent according to the relation
P(9)/P(l) = P(13)/P(5).
The above equation assumes that the fraction of total VLDL apo B
isolated in the preparation of large VLDL in the WHHL rabbits is the
same as the comparable fraction in the NZW rabbits. This assumption
is based on the similarity ofthe distributions of particle diameters from
large VLDL in NZW and WHHL rabbits obtained from electron pho-
tomicrographs.
(6) The ratio of fast to slow B particles in large VLDL from WHHL
rabbits is assumed equal to the ratio offast to slow B,E particles in large
VLDL from WHHL rabbits. This assumption allows P( 15) to be made
dependent according to the relation
P(15)/P(16) = P(13)/P(14).
This equation, which allows the unique estimation of the fractional
turnover rate of fast B particles (fractional irreversible loss from plasma
plus fractional rate of conversion to fast B,E particles) in WHHL
rabbits, is the most difficult to substantiate metabolically. However,
even ifthis constraint were to be in error by a wide margin, total apo B
transport in the WHHL rabbit would hardly be affected, given the
small contribution of this pathway to total apo B transport as seen in
Fig. 5.
(7) The remaining initial conditions, P(5), P(7), and P(13) are
uniquely resolvable with the other adjustable parameters subject to the
above mentioned constraints and tracer data shown in Fig. 3.
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